Commenting on the findings, Professor Rachel Kerr, study Senior Researcher, University of Oxford said: “Using these new data we are working fast to
Commenting on the findings, Professor Rachel Kerr, study Senior Researcher, University of Oxford said: “Using these new data we are working fast to identify trends and correlations, which will enable us to create a tiered risk assessment tool so we can more precisely define the risk to a given cancer patient and move away from a blanket “vulnerable” policy for all cancer patients, in the event of a second wave of COVID-19.”
Dr Lennard Lee, Academic Clinical Lecturer, University of Oxford said: “For the first time, we have a comprehensive analysis to determine who is more at risk of COVID-19. It is important to note that whilst cancer patients are more vulnerable, the chance of any given patient getting infected with COVID-19 remains low. People with cancer can be reassured that everything is being done in UK cancer centres to effectively minimise the risk of infection so that life-saving treatments can continue to be given”.
Professor Gary Middleton, University of Birmingham and Chair of the UK Coronavirus Cancer Monitoring Project, added: “Patients are turning to their oncologists and wanting to know exactly what is their risk from COVID-19. This is particularly important as the number of cases in Europe and the UK is still labile. The UKCCMP will continue to work to understand the effect of COVID-19 on cancer patients and cancer services to ensure the best possible care in the months ahead”.
What to do if you’re at high risk
According to the NHS, if you’re at high risk from coronavirus, you were advised to take extra steps to protect yourself until 1 August 2020 – this was called shielding.